It’s been almost a year since Solventum spun off as a separate business from 3M. Now, Solventum is orchestrating a spinoff of its own. On Tuesday, Solventum announced that it has lined up a deal ...

The Journal reported in October that Solventum, the healthcare company spun off from 3M last year, had retained bankers to explore a sale of its purification and filtration unit.

In the final days of November, I was getting slightly concerned about a long position in Solventum Corporation (NYSE:SOLV) after shares had enjoyed a partial re-rating. By now, the healthcare spin ...

Solventum currently has a consensus target price of $79.86, indicating a potential upside of 10.24%. As a group, “Surgical & medical instruments” companies have a potential upside of 34.78% ...

ST. PAUL, Minn., March 12, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today announced the launch of the Attest™ eBowie-Dick Test System (eBowie-Dick System), an ...

Waltham-based Thermo is buying the business from Solventum, a Minnesota-based company that spun off from manufacturing conglomerate 3M roughly one year ago. The business that Thermo is buying ...

Solventum faces significant challenges in its turnaround, including slow-growing core businesses, share loss, and margin pressures, but management has experience in driving operational ...

Shares of Solventum Corp. SOLV slipped 2.31% to $72.30 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.39% to 5,521.52 ...

Trian Fund Management, which beneficially owns about 5% of Solventum (SOLV) and is the company’s largest active shareholder, commented on Solventum’s recently announced sale of its ...

Shares in Solventum rallied 10% after Thermo Fisher Scientific said it would buy the healthcare company's purification and filtration business for about $4.1 billion.